0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Acute Migraine Medications Sales Market Report 2021
Published Date: June 2021
|
Report Code: QYRE-Auto-11B5506
Home | Market Reports | Health | Health Conditions | Pain Management
Global Acute Migraine Medications Sales Market Report 2021

Global Acute Migraine Medications Sales Market Report 2021

Code: QYRE-Auto-11B5506
Report
June 2021
134 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
The global Acute Migraine Medications market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Migraine Medications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

Triptans
NSAIDs
Others

Segment by Application

Drug Stores
Hospital Pharmacies
The Acute Migraine Medications market is analysed and market size information is provided by regions (countries). Segment by Application, the Acute Migraine Medications market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

BY COMPANY

GSK
Teva
Pfizer
Novartis
Merck
Sun Pharma
Grunenthal
Endo Pharmaceuticals
1 Acute Migraine Medications Market Overview
1.1 Acute Migraine Medications Product Scope
1.2 Acute Migraine Medications Segment by Type
1.2.1 Global Acute Migraine Medications Sales by Type (2016 & 2021 & 2027)
1.2.2 Triptans
1.2.3 NSAIDs
1.2.4 Others
1.3 Acute Migraine Medications Segment by Application
1.3.1 Global Acute Migraine Medications Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Drug Stores
1.3.3 Hospital Pharmacies
1.4 Acute Migraine Medications Market Estimates and Forecasts (2016-2027)
1.4.1 Global Acute Migraine Medications Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Acute Migraine Medications Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Acute Migraine Medications Price Trends (2016-2027)
2 Acute Migraine Medications Estimates and Forecasts by Region
2.1 Global Acute Migraine Medications Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Acute Migraine Medications Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Acute Migraine Medications Sales Market Share by Region (2016-2021)
2.2.2 Global Acute Migraine Medications Revenue Market Share by Region (2016-2021)
2.3 Global Acute Migraine Medications Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Acute Migraine Medications Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Acute Migraine Medications Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Acute Migraine Medications Estimates and Projections (2016-2027)
2.4.2 Europe Acute Migraine Medications Estimates and Projections (2016-2027)
2.4.3 China Acute Migraine Medications Estimates and Projections (2016-2027)
2.4.4 Japan Acute Migraine Medications Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Acute Migraine Medications Estimates and Projections (2016-2027)
2.4.6 India Acute Migraine Medications Estimates and Projections (2016-2027)
3 Global Acute Migraine Medications Competition Landscape by Players
3.1 Global Top Acute Migraine Medications Players by Sales (2016-2021)
3.2 Global Top Acute Migraine Medications Players by Revenue (2016-2021)
3.3 Global Acute Migraine Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acute Migraine Medications as of 2020)
3.4 Global Acute Migraine Medications Average Price by Company (2016-2021)
3.5 Manufacturers Acute Migraine Medications Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Acute Migraine Medications Market Size by Type
4.1 Global Acute Migraine Medications Historic Market Review by Type (2016-2021)
4.1.1 Global Acute Migraine Medications Sales Market Share by Type (2016-2021)
4.1.2 Global Acute Migraine Medications Revenue Market Share by Type (2016-2021)
4.1.3 Global Acute Migraine Medications Price by Type (2016-2021)
4.2 Global Acute Migraine Medications Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Acute Migraine Medications Sales Forecast by Type (2022-2027)
4.2.2 Global Acute Migraine Medications Revenue Forecast by Type (2022-2027)
4.2.3 Global Acute Migraine Medications Price Forecast by Type (2022-2027)
5 Global Acute Migraine Medications Market Size by Application
5.1 Global Acute Migraine Medications Historic Market Review by Application (2016-2021)
5.1.1 Global Acute Migraine Medications Sales Market Share by Application (2016-2021)
5.1.2 Global Acute Migraine Medications Revenue Market Share by Application (2016-2021)
5.1.3 Global Acute Migraine Medications Price by Application (2016-2021)
5.2 Global Acute Migraine Medications Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Acute Migraine Medications Sales Forecast by Application (2022-2027)
5.2.2 Global Acute Migraine Medications Revenue Forecast by Application (2022-2027)
5.2.3 Global Acute Migraine Medications Price Forecast by Application (2022-2027)
6 North America Acute Migraine Medications Market Facts & Figures
6.1 North America Acute Migraine Medications Sales by Company
6.1.1 North America Acute Migraine Medications Sales by Company (2016-2021)
6.1.2 North America Acute Migraine Medications Revenue by Company (2016-2021)
6.2 North America Acute Migraine Medications Sales Breakdown by Type
6.2.1 North America Acute Migraine Medications Sales Breakdown by Type (2016-2021)
6.2.2 North America Acute Migraine Medications Sales Breakdown by Type (2022-2027)
6.3 North America Acute Migraine Medications Sales Breakdown by Application
6.3.1 North America Acute Migraine Medications Sales Breakdown by Application (2016-2021)
6.3.2 North America Acute Migraine Medications Sales Breakdown by Application (2022-2027)
7 Europe Acute Migraine Medications Market Facts & Figures
7.1 Europe Acute Migraine Medications Sales by Company
7.1.1 Europe Acute Migraine Medications Sales by Company (2016-2021)
7.1.2 Europe Acute Migraine Medications Revenue by Company (2016-2021)
7.2 Europe Acute Migraine Medications Sales Breakdown by Type
7.2.1 Europe Acute Migraine Medications Sales Breakdown by Type (2016-2021)
7.2.2 Europe Acute Migraine Medications Sales Breakdown by Type (2022-2027)
7.3 Europe Acute Migraine Medications Sales Breakdown by Application
7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)
8 China Acute Migraine Medications Market Facts & Figures
8.1 China Acute Migraine Medications Sales by Company
8.1.1 China Acute Migraine Medications Sales by Company (2016-2021)
8.1.2 China Acute Migraine Medications Revenue by Company (2016-2021)
8.2 China Acute Migraine Medications Sales Breakdown by Type
8.2.1 China Acute Migraine Medications Sales Breakdown by Type (2016-2021)
8.2.2 China Acute Migraine Medications Sales Breakdown by Type (2022-2027)
8.3 China Acute Migraine Medications Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)
9 Japan Acute Migraine Medications Market Facts & Figures
9.1 Japan Acute Migraine Medications Sales by Company
9.1.1 Japan Acute Migraine Medications Sales by Company (2016-2021)
9.1.2 Japan Acute Migraine Medications Revenue by Company (2016-2021)
9.2 Japan Acute Migraine Medications Sales Breakdown by Type
9.2.1 Japan Acute Migraine Medications Sales Breakdown by Type (2016-2021)
9.2.2 Japan Acute Migraine Medications Sales Breakdown by Type (2022-2027)
9.3 Japan Acute Migraine Medications Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Acute Migraine Medications Market Facts & Figures
10.1 Southeast Asia Acute Migraine Medications Sales by Company
10.1.1 Southeast Asia Acute Migraine Medications Sales by Company (2016-2021)
10.1.2 Southeast Asia Acute Migraine Medications Revenue by Company (2016-2021)
10.2 Southeast Asia Acute Migraine Medications Sales Breakdown by Type
10.2.1 Southeast Asia Acute Migraine Medications Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Acute Migraine Medications Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Acute Migraine Medications Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Acute Migraine Medications Market Facts & Figures
11.1 India Acute Migraine Medications Sales by Company
11.1.1 India Acute Migraine Medications Sales by Company (2016-2021)
11.1.2 India Acute Migraine Medications Revenue by Company (2016-2021)
11.2 India Acute Migraine Medications Sales Breakdown by Type
11.2.1 India Acute Migraine Medications Sales Breakdown by Type (2016-2021)
11.2.2 India Acute Migraine Medications Sales Breakdown by Type (2022-2027)
11.3 India Acute Migraine Medications Sales Breakdown by Application
11.3.1 India Acute Migraine Medications Sales Breakdown by Application (2016-2021)
11.3.2 India Acute Migraine Medications Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Acute Migraine Medications Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Acute Migraine Medications Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Acute Migraine Medications Products Offered
12.1.5 GSK Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Business Overview
12.2.3 Teva Acute Migraine Medications Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Teva Acute Migraine Medications Products Offered
12.2.5 Teva Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Acute Migraine Medications Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Acute Migraine Medications Products Offered
12.3.5 Pfizer Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Business Overview
12.4.3 Novartis Acute Migraine Medications Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Acute Migraine Medications Products Offered
12.4.5 Novartis Recent Development
12.5 Merck
12.5.1 Merck Corporation Information
12.5.2 Merck Business Overview
12.5.3 Merck Acute Migraine Medications Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Merck Acute Migraine Medications Products Offered
12.5.5 Merck Recent Development
12.6 Sun Pharma
12.6.1 Sun Pharma Corporation Information
12.6.2 Sun Pharma Business Overview
12.6.3 Sun Pharma Acute Migraine Medications Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sun Pharma Acute Migraine Medications Products Offered
12.6.5 Sun Pharma Recent Development
12.7 Grunenthal
12.7.1 Grunenthal Corporation Information
12.7.2 Grunenthal Business Overview
12.7.3 Grunenthal Acute Migraine Medications Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Grunenthal Acute Migraine Medications Products Offered
12.7.5 Grunenthal Recent Development
12.8 Endo Pharmaceuticals
12.8.1 Endo Pharmaceuticals Corporation Information
12.8.2 Endo Pharmaceuticals Business Overview
12.8.3 Endo Pharmaceuticals Acute Migraine Medications Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Endo Pharmaceuticals Acute Migraine Medications Products Offered
12.8.5 Endo Pharmaceuticals Recent Development
13 Acute Migraine Medications Manufacturing Cost Analysis
13.1 Acute Migraine Medications Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Acute Migraine Medications
13.4 Acute Migraine Medications Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Acute Migraine Medications Distributors List
14.3 Acute Migraine Medications Customers
15 Market Dynamics
15.1 Acute Migraine Medications Market Trends
15.2 Acute Migraine Medications Drivers
15.3 Acute Migraine Medications Market Challenges
15.4 Acute Migraine Medications Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
    Table 1. Global Acute Migraine Medications Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Acute Migraine Medications Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Acute Migraine Medications Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Acute Migraine Medications Sales (K Units) by Region (2016-2021)
    Table 5. Global Acute Migraine Medications Sales Market Share by Region (2016-2021)
    Table 6. Global Acute Migraine Medications Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Acute Migraine Medications Revenue Share by Region (2016-2021)
    Table 8. Global Acute Migraine Medications Sales (K Units) Forecast by Region (2022-2027)
    Table 9. Global Acute Migraine Medications Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Acute Migraine Medications Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Acute Migraine Medications Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Acute Migraine Medications Sales (K Units) of Key Companies (2016-2021)
    Table 13. Global Acute Migraine Medications Sales Share by Company (2016-2021)
    Table 14. Global Acute Migraine Medications Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Acute Migraine Medications Revenue Share by Company (2016-2021)
    Table 16. Global Acute Migraine Medications by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Migraine Medications as of 2020)
    Table 17. Global Acute Migraine Medications Average Price (US$/Unit) of Key Company (2016-2021)
    Table 18. Manufacturers Acute Migraine Medications Manufacturing Sites and Area Served
    Table 19. Manufacturers Acute Migraine Medications Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Acute Migraine Medications Sales (K Units) by Type (2016-2021)
    Table 22. Global Acute Migraine Medications Sales Share by Type (2016-2021)
    Table 23. Global Acute Migraine Medications Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Acute Migraine Medications Price (US$/Unit) by Type (2016-2021)
    Table 25. Global Acute Migraine Medications Sales Share by Type (2022-2027)
    Table 26. Global Acute Migraine Medications Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 27. Global Acute Migraine Medications Revenue Share by Type (2022-2027)
    Table 28. Global Acute Migraine Medications Price (US$/Unit) by Type (2022-2027)
    Table 29. Global Acute Migraine Medications Sales (K Units) by Application (2016-2021)
    Table 30. Global Acute Migraine Medications Sales Share by Application (2016-2021)
    Table 31. Global Acute Migraine Medications Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Acute Migraine Medications Price (US$/Unit) by Application (2016-2021)
    Table 33. Global Acute Migraine Medications Sales (K Units) by Application (2022-2027)
    Table 34. Global Acute Migraine Medications Sales Share by Application (2022-2027)
    Table 35. Global Acute Migraine Medications Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Acute Migraine Medications Revenue Share by Application (2022-2027)
    Table 37. Global Acute Migraine Medications Price (US$/Unit) by Application (2022-2027)
    Table 38. North America Acute Migraine Medications Sales (K Units) by Company (2016-2021)
    Table 39. North America Acute Migraine Medications Sales Market Share by Company (2016-2021)
    Table 40. North America Acute Migraine Medications Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Acute Migraine Medications Revenue Market Share by Company (2016-2021)
    Table 42. North America Acute Migraine Medications Sales by Type (2016-2021) & (K Units)
    Table 43. North America Acute Migraine Medications Sales Market Share by Type (2016-2021)
    Table 44. North America Acute Migraine Medications Sales by Type (2022-2027) & (K Units)
    Table 45. North America Acute Migraine Medications Sales Market Share by Type (2022-2027)
    Table 46. North America Acute Migraine Medications Sales by Application (2016-2021) & (K Units)
    Table 47. North America Acute Migraine Medications Sales Market Share by Application (2016-2021)
    Table 48. North America Acute Migraine Medications Sales by Application (2022-2027) & (K Units)
    Table 49. North America Acute Migraine Medications Sales Market Share by Application (2022-2027)
    Table 50. Europe Acute Migraine Medications Sales (K Units) by Company (2016-2021)
    Table 51. Europe Acute Migraine Medications Sales Market Share by Company (2016-2021)
    Table 52. Europe Acute Migraine Medications Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Acute Migraine Medications Revenue Market Share by Company (2016-2021)
    Table 54. Europe Acute Migraine Medications Sales by Type (2016-2021) & (K Units)
    Table 55. Europe Acute Migraine Medications Sales Market Share by Type (2016-2021)
    Table 56. Europe Acute Migraine Medications Sales by Type (2022-2027) & (K Units)
    Table 57. Europe Acute Migraine Medications Sales Market Share by Type (2022-2027)
    Table 58. Europe Acute Migraine Medications Sales by Application (2016-2021) & (K Units)
    Table 59. Europe Acute Migraine Medications Sales Market Share by Application (2016-2021)
    Table 60. Europe Acute Migraine Medications Sales by Application (2022-2027) & (K Units)
    Table 61. Europe Acute Migraine Medications Sales Market Share by Application (2022-2027)
    Table 62. China Acute Migraine Medications Sales (K Units) by Company (2016-2021)
    Table 63. China Acute Migraine Medications Sales Market Share by Company (2016-2021)
    Table 64. China Acute Migraine Medications Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Acute Migraine Medications Revenue Market Share by Company (2016-2021)
    Table 66. China Acute Migraine Medications Sales by Type (2016-2021) & (K Units)
    Table 67. China Acute Migraine Medications Sales Market Share by Type (2016-2021)
    Table 68. China Acute Migraine Medications Sales by Type (2022-2027) & (K Units)
    Table 69. China Acute Migraine Medications Sales Market Share by Type (2022-2027)
    Table 70. China Acute Migraine Medications Sales by Application (2016-2021) & (K Units)
    Table 71. China Acute Migraine Medications Sales Market Share by Application (2016-2021)
    Table 72. China Acute Migraine Medications Sales by Application (2022-2027) & (K Units)
    Table 73. China Acute Migraine Medications Sales Market Share by Application (2022-2027)
    Table 74. Japan Acute Migraine Medications Sales (K Units) by Company (2016-2021)
    Table 75. Japan Acute Migraine Medications Sales Market Share by Company (2016-2021)
    Table 76. Japan Acute Migraine Medications Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Acute Migraine Medications Revenue Market Share by Company (2016-2021)
    Table 78. Japan Acute Migraine Medications Sales by Type (2016-2021) & (K Units)
    Table 79. Japan Acute Migraine Medications Sales Market Share by Type (2016-2021)
    Table 80. Japan Acute Migraine Medications Sales by Type (2022-2027) & (K Units)
    Table 81. Japan Acute Migraine Medications Sales Market Share by Type (2022-2027)
    Table 82. Japan Acute Migraine Medications Sales by Application (2016-2021) & (K Units)
    Table 83. Japan Acute Migraine Medications Sales Market Share by Application (2016-2021)
    Table 84. Japan Acute Migraine Medications Sales by Application (2022-2027) & (K Units)
    Table 85. Japan Acute Migraine Medications Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Acute Migraine Medications Sales (K Units) by Company (2016-2021)
    Table 87. Southeast Asia Acute Migraine Medications Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Acute Migraine Medications Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Acute Migraine Medications Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Acute Migraine Medications Sales by Type (2016-2021) & (K Units)
    Table 91. Southeast Asia Acute Migraine Medications Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Acute Migraine Medications Sales by Type (2022-2027) & (K Units)
    Table 93. Southeast Asia Acute Migraine Medications Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Acute Migraine Medications Sales by Application (2016-2021) & (K Units)
    Table 95. Southeast Asia Acute Migraine Medications Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Acute Migraine Medications Sales by Application (2022-2027) & (K Units)
    Table 97. Southeast Asia Acute Migraine Medications Sales Market Share by Application (2022-2027)
    Table 98. India Acute Migraine Medications Sales (K Units) by Company (2016-2021)
    Table 99. India Acute Migraine Medications Sales Market Share by Company (2016-2021)
    Table 100. India Acute Migraine Medications Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Acute Migraine Medications Revenue Market Share by Company (2016-2021)
    Table 102. India Acute Migraine Medications Sales by Type (2016-2021) & (K Units)
    Table 103. India Acute Migraine Medications Sales Market Share by Type (2016-2021)
    Table 104. India Acute Migraine Medications Sales by Type (2022-2027) & (K Units)
    Table 105. India Acute Migraine Medications Sales Market Share by Type (2022-2027)
    Table 106. India Acute Migraine Medications Sales by Application (2016-2021) & (K Units)
    Table 107. India Acute Migraine Medications Sales Market Share by Application (2016-2021)
    Table 108. India Acute Migraine Medications Sales by Application (2022-2027) & (K Units)
    Table 109. India Acute Migraine Medications Sales Market Share by Application (2022-2027)
    Table 110. GSK Corporation Information
    Table 111. GSK Description and Business Overview
    Table 112. GSK Acute Migraine Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 113. GSK Acute Migraine Medications Product
    Table 114. GSK Recent Development
    Table 115. Teva Corporation Information
    Table 116. Teva Description and Business Overview
    Table 117. Teva Acute Migraine Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 118. Teva Acute Migraine Medications Product
    Table 119. Teva Recent Development
    Table 120. Pfizer Corporation Information
    Table 121. Pfizer Description and Business Overview
    Table 122. Pfizer Acute Migraine Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 123. Pfizer Acute Migraine Medications Product
    Table 124. Pfizer Recent Development
    Table 125. Novartis Corporation Information
    Table 126. Novartis Description and Business Overview
    Table 127. Novartis Acute Migraine Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 128. Novartis Acute Migraine Medications Product
    Table 129. Novartis Recent Development
    Table 130. Merck Corporation Information
    Table 131. Merck Description and Business Overview
    Table 132. Merck Acute Migraine Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 133. Merck Acute Migraine Medications Product
    Table 134. Merck Recent Development
    Table 135. Sun Pharma Corporation Information
    Table 136. Sun Pharma Description and Business Overview
    Table 137. Sun Pharma Acute Migraine Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 138. Sun Pharma Acute Migraine Medications Product
    Table 139. Sun Pharma Recent Development
    Table 140. Grunenthal Corporation Information
    Table 141. Grunenthal Description and Business Overview
    Table 142. Grunenthal Acute Migraine Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 143. Grunenthal Acute Migraine Medications Product
    Table 144. Grunenthal Recent Development
    Table 145. Endo Pharmaceuticals Corporation Information
    Table 146. Endo Pharmaceuticals Acute Migraine Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 147. Endo Pharmaceuticals Description and Business Overview
    Table 148. Endo Pharmaceuticals Acute Migraine Medications Product
    Table 149. Endo Pharmaceuticals Recent Development
    Table 150. Production Base and Market Concentration Rate of Raw Material
    Table 151. Key Suppliers of Raw Materials
    Table 152. Acute Migraine Medications Distributors List
    Table 153. Acute Migraine Medications Customers List
    Table 154. Acute Migraine Medications Market Trends
    Table 155. Acute Migraine Medications Market Drivers
    Table 156. Acute Migraine Medications Market Challenges
    Table 157. Acute Migraine Medications Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Acute Migraine Medications Product Picture
    Figure 2. Global Acute Migraine Medications Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Acute Migraine Medications Sales Market Share by Application in 2021 & 2027
    Figure 6. Drug Stores Examples
    Figure 7. Hospital Pharmacies Examples
    Figure 8. Global Acute Migraine Medications Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 9. Global Acute Migraine Medications Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 10. Global Acute Migraine Medications Sales (K Units) Growth Rate (2016-2027)
    Figure 11. Global Acute Migraine Medications Price Trends Growth Rate (2016-2027) (US$/Unit)
    Figure 12. Global Acute Migraine Medications Revenue Market Share by Region: 2016 VS 2021
    Figure 13. Global Acute Migraine Medications Revenue Market Share by Region: 2021 VS 2027
    Figure 14. North America Acute Migraine Medications Revenue (Million USD) Growth Rate (2016-2027)
    Figure 15. North America Acute Migraine Medications Sales (K Units) Growth Rate (2016-2027)
    Figure 16. Europe Acute Migraine Medications Revenue (Million USD) Growth Rate (2016-2027)
    Figure 17. Europe Acute Migraine Medications Sales (Million USD) Growth Rate (2016-2027)
    Figure 18. China Acute Migraine Medications Revenue (Million USD) Growth Rate (2016-2027)
    Figure 19. China Acute Migraine Medications Sales (Million USD) and Growth Rate (2016-2027)
    Figure 20. Japan Acute Migraine Medications Revenue (Million USD) Growth Rate (2016-2027)
    Figure 21. Japan Acute Migraine Medications Sales (Million USD) Growth Rate (2016-2027)
    Figure 22. Southeast Asia Acute Migraine Medications Revenue (Million USD) Growth Rate (2016-2027)
    Figure 23. Southeast Asia Acute Migraine Medications Sales (Million USD) Growth Rate (2016-2027)
    Figure 24. India Acute Migraine Medications Revenue (Million USD) Growth Rate (2016-2027)
    Figure 25. India Acute Migraine Medications Sales (Million USD) Growth Rate (2016-2027)
    Figure 26. Global 5 Largest Acute Migraine Medications Players Market Share by Revenue in Acute Migraine Medications: 2016 & 2020
    Figure 27. Acute Migraine Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 28. Global Acute Migraine Medications Revenue Share by Type (2016-2021)
    Figure 29. Global Acute Migraine Medications Revenue Growth Rate by Type in 2016 & 2020
    Figure 30. Global Acute Migraine Medications Revenue Share by Application (2016-2021)
    Figure 31. Global Acute Migraine Medications Revenue Growth Rate by Application in 2016 & 2020
    Figure 32. North America Acute Migraine Medications Sales Market Share by Type in 2020
    Figure 33. North America Acute Migraine Medications Sales Market Share by Application in 2020
    Figure 34. Europe Acute Migraine Medications Sales Market Share by Type in 2020
    Figure 35. Europe Acute Migraine Medications Sales Market Share by Application in 2020
    Figure 36. China Acute Migraine Medications Sales Market Share by Type in 2020
    Figure 37. China Acute Migraine Medications Sales Market Share by Application in 2020
    Figure 38. Japan Acute Migraine Medications Sales Market Share by Type in 2020
    Figure 39. Japan Acute Migraine Medications Sales Market Share by Application in 2020
    Figure 40. Southeast Asia Acute Migraine Medications Sales Market Share by Type in 2020
    Figure 41. Southeast Asia Acute Migraine Medications Sales Market Share by Application in 2020
    Figure 42. India Acute Migraine Medications Sales Market Share by Type in 2020
    Figure 43. India Acute Migraine Medications Sales Market Share by Application in 2020
    Figure 44. Key Raw Materials Price Trend
    Figure 45. Manufacturing Cost Structure of Acute Migraine Medications
    Figure 46. Manufacturing Process Analysis of Acute Migraine Medications
    Figure 47. Acute Migraine Medications Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4000
This license allows only one user to access the PDF.

Electronic (PDF)
$6000
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$8000
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network